Geometric realizations of generalized algebraic curvature operators

Autor: Gilkey, P., Nikcevic, S., Westerman, D.

We study the 8 natural GL equivariant geometric realization questions for the space of generalized algebraic curvature tensors. All but one of them is solvable; a non-zero projectively flat Ricci antisymmetric generalized algebraic curvature is not g

Externí odkaz: http://arxiv.org/abs/0811.3180

The frequency, manifestations, and duration of prolonged cytopenias after first-line fludarabine combination chemotherapy

Autor: Gill, S., Carney, D., Ritchie, D., Wolf, M., Westerman, D., Prince, H.M., Januszewicz, H., Seymour, J.F. ^*

Publikováno v: In Annals of Oncology February 2010 21(2):331-334

Extraction of Amaranth seed oil by supercritical carbon dioxide

Autor: Westerman, D., Santos, R.C.D., Bosley, J.A., Rogers, J.S., Al-Duri, B.

Publikováno v: In The Journal of Supercritical Fluids 2006 37(1):38-52

Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry:An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project

Autor: Rawstron, AC, Kreuzer, K-A, Soosapilla, A, Spacek, M, Stehlikova, O, Gambell, P, McIver-Brown, N, Villamor, N, Psarra, K, Arroz, M, Milani, R, de la Serna, J, Cedena, MT, Jaksic, O, Nomdedeu, J, Moreno, C, Rigolin, GM, Cuneo, A, Johansen, P, Johnsen, HE, Rosenquist, R, Niemann, CU, Kern, W, Westerman, D, Trneny, M, Mulligan, S, Doubek, M, Pospisilova, S, Hillmen, P, Oscier, D, Hallek, M, Ghia, P, Montserrat, E

Publikováno v: Rawstron, A C, Kreuzer, K, Soosapilla, A, Spacek, M, Stehlikova, O, Gambell, P, Mciver-brown, N, Villamor, N, Psarra, K, Arroz, M, Milani, R, De La Serna, J, Cedena, M T, Jaksic, O, Nomdedeu, J, Moreno, C, Rigolin, G M, Cuneo, A, Johansen, P, Johnsen, H E, Rosenquist, R, Niemann, C U, Kern, W, Westerman, D, Trneny, M, Mulligan, S, Doubek, M, Pospisilova, S, Hillmen, P, Oscier, D, Hallek, M, Ghia, P & Montserrat, E 2018, ' Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry : An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project ', Cytometry. Part B: Clinical Cytometry, vol. 94, no. 1, pp. 121-128 . https://doi.org/10.1002/cyto.b.21595
Rawstron, A C, Kreuzer, K-A, Soosapilla, A, Spacek, M, Stehlikova, O, Gambell, P, McIver-Brown, N, Villamor, N, Psarra, K, Arroz, M, Milani, R, de la Serna, J, Cedena, M T, Jaksic, O, Nomdedeu, J, Moreno, C, Rigolin, G M, Cuneo, A, Johansen, P, Johnsen, H E, Rosenquist, R, Niemann, C U, Kern, W, Westerman, D, Trneny, M, Mulligan, S, Doubek, M, Pospisilova, S, Hillmen, P, Oscier, D, Hallek, M, Ghia, P & Montserrat, E 2018, ' Reproducible diagnosis of Chronic Lymphocytic Leukemia by flow cytometry : An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project ', Cytometry. Part B: Clinical Cytometry, vol. 94, no. 1, pp. 121-128 . https://doi.org/10.1002/cyto.b.21595
Cytometry. Part B, Clinical Cytometry
CYTOMETRY PART B-CLINICAL CYTOMETRY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

The diagnostic criteria for CLL rely on morphology and immunophenotype. Current approaches have limitations affecting reproducibility and there is no consensus on the role of new markers. The aim of this project was to identify reproducible criteria

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::df5bb5f57d8305a42d707dab013dbc73
https://curis.ku.dk/ws/files/228312240/cyto.b.21595_10.1002_ISSN_1552_4957.2018iccs_virutal_collection.pdf

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study

Autor: Rawstron, AC, Fazi, C, Agathangelidis, A, Villamor, N, Letestu, R, Nomdedeu, J, Palacio, C, Stehlikova, O, Kreuzer, K-A, Liptrot, S, O'Brien, D, de Tute, RM, Marinov, I, Hauwel, M, Spacek, M, Dobber, J, Kater, AP, Gambell, P, Soosapilla, A, Lozanski, G, Brachtl, G, Lin, K, Boysen, J, Hanson, C, Jorgensen, JL, Stetler-Stevenson, M, Yuan, C, Broome, HE, Rassenti, L, Craig, F, Delgado, J, Moreno, C, Bosch, F, Egle, A, Doubek, M, Pospisilova, S, Mulligan, S, Westerman, D, Sanders, CM, Emerson, R, Robins, HS, Kirsch, I, Shanafelt, T, Pettitt, A, Kipps, TJ, Wierda, WG, Cymbalista, F, Hallek, M, Hillmen, P, Montserrat, E, Ghia, P, CLL, ERIC European Res Initiative

Publikováno v: Leukemia
Leukemia, vol 30, iss 4
Leukemia, 30(4), 929-936. Nature Publishing Group
LEUKEMIA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

In chronic lymphocytic leukemia (CLL) the level of minimal residual disease (MRD) after therapy is an independent predictor of outcome. Given the increasing number of new agents being explored for CLL therapy, using MRD as a surrogate could greatly r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::223b87a88cadbba63e43e546bd4fa680